![]() |
JOURNAL TOOLS |
Opzioni di pubblicazione |
eTOC |
Per abbonarsi |
Sottometti un articolo |
Segnala alla tua biblioteca |
ARTICLE TOOLS |
Publication history |
Estratti |
Permessi |
Per citare questo articolo |
Share |


I TUOI DATI
I TUOI ORDINI
CESTINO ACQUISTI
N. prodotti: 0
Totale ordine: € 0,00
COME ORDINARE
I TUOI ABBONAMENTI
I TUOI ARTICOLI
I TUOI EBOOK
COUPON
ACCESSIBILITÀ
CASE REPORT
Chirurgia 2021 October;34(5):222-6
DOI: 10.23736/S0394-9508.20.05227-4
Copyright © 2020 EDIZIONI MINERVA MEDICA
lingua: Inglese
Breast implant-associated anaplastic large cell lymphoma: case report and literature review
Rebecca J. FISHER 1 ✉, Kishan P. PAREKH 1, Rebecca HARSTEN 2, Philip IDAEWOR 1, Abdalla SAAD ABDALLA AL-ZAWI 1, Wayne CHICKEN 1
1 Department of Surgery, Basildon and Thurrock University Hospital, Basildon, UK; 2 Department of Surgery, Royal London Hospital, London, UK
The number of reported cases of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is increasing along with attention and discussion amongst physicians. After first being described in 1997, the World Health Organization in 2016 classified BIA-ALCL as a mature T cell neoplasm. This increasing acknowledgment and awareness will help in guiding management towards appropriate diagnosis and effective treatment. BIA-ALCL is originally a T-cell lymphoma, where the malignant T-cells have a large pleomorphic and anaplastic morphology. The immuno-histochemistry expresses immuno-reactivity to CD30. It is an anaplastic lymphoma kinase (ALK) surface receptor negative anaplastic large cell lymphoma. We present an additional case of BIA-ALCL, the presentation and management; and provide an overview of the literature related to this condition.
KEY WORDS: Lymphoma, large-cell, anaplastic; T-lymphocytes, cytotoxic; Breast implants